KRAS and neoplasm: For example, miR-143 has been shown to act as a tumor suppressor in NSCLC, cervical cancer, prostate cancer, ovarian cancer, colon cancer, and leukemia, being able to silence not only KRAS but also RAS-effector signal genes Erk and Akt [109].